NasdaqGS:NEOGMedical Equipment
Neogen (NEOG) Returns To Quarterly Profitability Challenging Persistent Bearish Loss Narratives
Neogen (NEOG) has just put Q2 2026 under the microscope with total revenue of US$209.2 million and basic EPS of US$0.17, providing a clear snapshot of where the business sits after a stretch of heavy losses. The company has seen quarterly revenue move from US$216.9 million in Q1 2025 to US$231.3 million in Q2 2025, then US$220.98 million in Q3 and US$225.5 million in Q4 2025 before landing at US$209.2 million in Q1 2026. Over the same periods, basic EPS went from a loss of US$0.06 to losses...